Dr. Steven Polyak, MD
Claim this profileUniversity of Iowa Hospitals and Clinics
Studies Perianal Fistulas
Studies Crohn's Disease
6 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Steven Polyak, MD is currently running
TAK-279
for Ulcerative Colitis
The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate any problems. The participants will take capsules of either TAK-279 or placebo for up to 3 months (12 weeks). Then all the participants will receive TAK-279 for the rest of the treatment part of the study (1 year or 52 weeks). During the study, participants will visit their study clinic several times.
Recruiting0 awards Phase 21 criteria
ABX464
for Ulcerative Colitis
This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinical remission in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies \[corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)\] and/or advanced therapies \[biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors\].
Recruiting1 award Phase 36 criteria
More about Steven Polyak, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Steven Polyak, MD has experience with
- TAK-279
- ABX464
- Placebo
- BMS-986165
- CDPATH™
Breakdown of trials Steven Polyak, MD has run
Perianal Fistulas
Crohn's Disease
Ulcerative Colitis
Campylobacter Colitis
Administration site ulcer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven Polyak, MD specialize in?
Steven Polyak, MD focuses on Perianal Fistulas and Crohn's Disease. In particular, much of their work with Perianal Fistulas has involved treating patients, or patients who are undergoing treatment.
Is Steven Polyak, MD currently recruiting for clinical trials?
Yes, Steven Polyak, MD is currently recruiting for 4 clinical trials in Iowa City Iowa. If you're interested in participating, you should apply.
Are there any treatments that Steven Polyak, MD has studied deeply?
Yes, Steven Polyak, MD has studied treatments such as TAK-279, ABX464, Placebo.
What is the best way to schedule an appointment with Steven Polyak, MD?
Apply for one of the trials that Steven Polyak, MD is conducting.
What is the office address of Steven Polyak, MD?
The office of Steven Polyak, MD is located at: University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242 United States. This is the address for their practice at the University of Iowa Hospitals and Clinics.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.